🚀 VC round data is live in beta, check it out!
Medica Sur Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medica Sur and similar public comparables like Pihlajalinna, M1 Kliniken, Mater Dei, Auna and more.
Medica Sur Overview
About Medica Sur
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
Founded
1966
HQ
Employees
3.5K
Website
Sectors
Financials (LTM)
EV
$293M
Medica Sur Financials
Medica Sur reported last 12-month revenue of $279M and EBITDA of $59M.
In the same LTM period, Medica Sur generated $100M in gross profit, $59M in EBITDA, and $32M in net income.
Revenue (LTM)
Medica Sur P&L
In the most recent fiscal year, Medica Sur reported revenue of $279M and EBITDA of $61M.
Medica Sur expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $279M | XXX | $279M | XXX | XXX | XXX |
| Gross Profit | $100M | XXX | $95M | XXX | XXX | XXX |
| Gross Margin | 36% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | $59M | XXX | $61M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 22% | XXX | XXX | XXX |
| EBIT Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $32M | XXX | $31M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medica Sur Stock Performance
Medica Sur has current market cap of $323M, and enterprise value of $293M.
Market Cap Evolution
Medica Sur's stock price is $3.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $293M | $323M | 0.0% | XXX | XXX | XXX | $0.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedica Sur Valuation Multiples
Medica Sur trades at 1.0x EV/Revenue multiple, and 5.0x EV/EBITDA.
EV / Revenue (LTM)
Medica Sur Financial Valuation Multiples
As of April 2, 2026, Medica Sur has market cap of $323M and EV of $293M.
Equity research analysts estimate Medica Sur's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medica Sur has a P/E ratio of 10.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $323M | XXX | $323M | XXX | XXX | XXX |
| EV (current) | $293M | XXX | $293M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 5.0x | XXX | 4.8x | XXX | XXX | XXX |
| EV/EBIT | 6.2x | XXX | 6.3x | XXX | XXX | XXX |
| EV/Gross Profit | 2.9x | XXX | 3.1x | XXX | XXX | XXX |
| P/E | 10.2x | XXX | 10.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 6.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medica Sur Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medica Sur Margins & Growth Rates
Medica Sur's revenue in the last 12 month grew by 1%.
Medica Sur's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Medica Sur's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medica Sur's rule of X is 35% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Medica Sur Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | (0%) | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | (3%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 35% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 20% | XXX | 20% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medica Sur Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pihlajalinna | XXX | XXX | XXX | XXX | XXX | XXX |
| M1 Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Mater Dei | XXX | XXX | XXX | XXX | XXX | XXX |
| Auna | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medica Sur M&A Activity
Medica Sur acquired XXX companies to date.
Last acquisition by Medica Sur was on XXXXXXXX, XXXXX. Medica Sur acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medica Sur
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedica Sur Investment Activity
Medica Sur invested in XXX companies to date.
Medica Sur made its latest investment on XXXXXXXX, XXXXX. Medica Sur invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medica Sur
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medica Sur
| When was Medica Sur founded? | Medica Sur was founded in 1966. |
| Where is Medica Sur headquartered? | Medica Sur is headquartered in Mexico. |
| How many employees does Medica Sur have? | As of today, Medica Sur has over 3K employees. |
| Is Medica Sur publicly listed? | Yes, Medica Sur is a public company listed on Bolsa Mexicana de Valores. |
| What is the stock symbol of Medica Sur? | Medica Sur trades under MEDICAB ticker. |
| When did Medica Sur go public? | Medica Sur went public in 1994. |
| Who are competitors of Medica Sur? | Medica Sur main competitors are Pihlajalinna, M1 Kliniken, Mater Dei, Auna. |
| What is the current market cap of Medica Sur? | Medica Sur's current market cap is $323M. |
| What is the current revenue of Medica Sur? | Medica Sur's last 12 months revenue is $279M. |
| What is the current revenue growth of Medica Sur? | Medica Sur revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Medica Sur? | Current revenue multiple of Medica Sur is 1.0x. |
| Is Medica Sur profitable? | Yes, Medica Sur is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medica Sur? | Medica Sur's last 12 months EBITDA is $59M. |
| What is Medica Sur's EBITDA margin? | Medica Sur's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Medica Sur? | Current EBITDA multiple of Medica Sur is 5.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.